Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis

For the first time, a novel aptamer was designed and utilized for the selective detection of rivaroxaban (RIV) using the integration of bioinformatics with biosensing technology. The selected aptamer with the sequence 5′-TAG GGA AGA GAA GGA CAT ATG ATG ACT CAC AAC TGG ACG AAC GTA CTT ATC CCC CCC AAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebrahimi, Rokhsareh, Barzegari, Abolfazl, Teimuri-Mofrad, Reza, Kordasht, Houman Kholafazad, Hasanzadeh, Mohammad, Khoubnasabjafari, Maryam, Jouyban-Gharamaleki, Vahid, Rad, Abbas Afrasiabi, Shadjou, Nasrin, Rashidi, Mohammad-Reza, Afshar Mogaddam, Mohammad Reza, Jouyban, Abolghasem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599351/
https://www.ncbi.nlm.nih.gov/pubmed/36290911
http://dx.doi.org/10.3390/bios12100773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599351/
https://www.ncbi.nlm.nih.gov/pubmed/36290911
http://dx.doi.org/10.3390/bios12100773

Ejemplares similares